1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References

Telomeres, located at the end of linear chromosomes, are essential to maintain genomic stability. Telomere biology has recently emerged as an important player in the fields of ageing and disease. To maintain telomere length (TL) and reduce its degradation after mitosis, the telomerase enzyme complex is produced. Genetic, epigenetic, hormonal and environmental factors can regulate telomerase function. These include stress hormones such as cortisol and growth factors. The hypothalamic–pituitary–adrenal (HPA) axis has been evaluated in psychiatric diseases where hypercortisolism and oxidative stress are often present. Some researches have linked TL shortening to increases in stress-related cortisol, but others have not. The effects of cortisol on the telomere system are complex and may depend on the intensity and duration of exposure. On the other hand, low levels of IGF-1 are associated with inflammation and ageing-related diseases (ischaemic heart disease, congestive heart failure). Both IGF-1 and TL diminish with age and are positively and strongly correlated with each other. It is not clear whether this positive correlation reflects a single association or a cause–effect relationship. Further research will ideally investigate longitudinal changes in telomeres and both these hormonal axes. To our knowledge, TL dysfunction has not been described in either endogenous hypercortisolism (Cushing's syndrome) or acromegaly where excessive amounts of GH and consequently IGF-1 are produced. This review focuses on the possible relationships between telomere dysfunction and the hypothalamic–pituitary–adrenal (HPA) axis and GH-IGF-1 system.


  1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References

Telomeres are noncoding repetitive DNA sequences, composed of multiple repetitions of a guanine-rich sequence (TTAGGG), located at the end of linear chromosomes, and protecting them from erosion and end-to-end chromosome fusion. These sequences are covered by a protein complex called Shelterin, which stabilize and protect them. Without telomeres, genetic material could be lost after every cell division; thus, when telomeres are critically short, cell division stops and senescence and apoptosis are induced.[1] Telomere biology has recently emerged as an important player in the fields of ageing and disease.

To avoid telomere attrition and to maintain telomere length, germ-line cells and a few somatic cells produce telomerase. Telomerase is a specific enzymatic complex involved in telomere repair and elongation. It catalyses telomeric DNA synthesis to reduce chromosomal end degradation after terminal DNA replication and thus maintain telomere length (TL).[2] Telomerase consists of several components, the catalytic component (hTERT) with telomerase reverse transcriptase activity, the telomerase RNA component (TERC) that is used by hTERT as a template to synthesize telomere DNA, dyskerin complex and several proteins which stabilize the whole telomerase machinery.[3]

Telomere length typically decreases with ageing, but the shortening rate is not uniform for all kind of tissues and cells; for example, brain cells and cardiomyocytes show few attritions.[4, 5] Undifferentiated stem cells have longer TL, while in more differentiated cells, TL are shorter.[6] Even in ‘nondividing’ cells, telomeres can be shortened by oxidative stress, which preferentially damages guanine-rich sequences as telomeres, to a greater extent than nontelomeric DNA.[7, 8] Stem cell dysfunction provoked by telomere shortening may be one of the mechanisms responsible for ageing.[9] Moreover, TL is considerably heterogeneous, even in the same cell and for individuals of similar age. Recent studies revealed that TL changes could be dependent on the baseline TL (newborns). In early life, inheritance seems to be an important point, being one of the main determinants of TL. However, the inherited impact decreases with increasing age, due to the effects of environmental factors on TL.[10, 11]

Genetic, epigenetic and enviromental factors can regulate telomerase function. These include socio-economic status, lifestyle, autoimmunity, histone methylation and acetylation, stress level, hormones (stress hormones such as cortisol, catecholamines and sex hormones), growth factors, personal habits (smoking, diet, physical exercise) and drugs (such us angiotensin-converting enzyme inhibitors and resveratrol), which can influence and modulate telomerase dynamics and activity.[1] Processes known to modulate telomerase dynamics and to affect telomere length either by shortening or lengthening are summarized in Figure 1. Some behavioural and psychological interventions such as long-term exercise or cognitive behavioural stress management have been shown to increase telomerase activity.[12, 13] However, one limitation to most behavioural interventions is poor long-term maintenance of behavioural changes, as these biochemical changes may only last as long as the behavioural and psychological changes are maintained.


Figure 1. Processes known to affect telomere length either by shortening or lengthening (CTC1: conserved telomere maintenance complex component 1; IGF-1: insulin-like growth factor type 1; TERT: Telomerase reverse transcriptase; TERC: Telomerase RNA component; ATRX: ATP-dependent helicase; DAXX: death associated protein 6; ACEI: angiotensin-converting enzyme inhibitors).

Download figure to PowerPoint

Measuring TL may contribute to the understanding of its clinical and biological significance, as it can be used as an indicator of chromosome stability, telomerase activity, proliferative capacity and cellular ageing. Different methods are available to determine TL, each with specific features.[2, 14] However, up to now they have mostly been in experimental research rather than in clinical diagnosis and prognosis, for which improvements in cost-effectiveness, sensitivity and availability of large numbers of patients would be necessary.

Therefore, telomere biology can be involved in the pathophysiology of several clinical entities such as cancer,[15] premalignant lesions, aplastic anaemia,[16] fibrosis of the lungs and liver, dyskeratosis congenita, ageing and as a risk factor for cardiovascular disease[17] (poor lipid profile, high systolic blood pressure, fasting glucose, smoking, greater abdominal adiposity).[5, 6] Whether a common molecular mechanism is causally involved in the development of these human conditions requires further research with prospective, longitudinal and interventional studies.

Some endocrine diseases like adrenal and GH dysfunction are associated with ageing-like processes and increased cardiovascular risk, but the underlying mechanisms are complex and not always clear. Given the role of telomeres in some of these mechanisms, we decided to review what evidence there was to associate the telomere system with endocrine dysfunction of the hypothalamic–pituitary–adrenal (HPA) axis and the GH/IGF-1 system.

Hypothalamic–pituitary–adrenal axis and the telomere system

  1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References

To our knowledge, telomere dysfunction has not been described in endogenous hypercortisolism due to Cushing's disease or adrenal adenomas, nor in the more common situation of exogenous hypercortisolism after glucocorticoid (GC) therapy.[18]

In contrast, it has been evaluated in different psychiatric diseases like acute and chronic stress and post-traumatic stress disorder, where hypercortisolism is often present, representing another model of endogenous hypercortisolism. However, these neuropsychiatric conditions are not the best model of hypercortisolism on which to base conclusions about telomere dynamics, due to their complexity with concurrent changes in stress hormones, neurotransmitters, autonomic activity, cytokines, inflammation and oxidative factors.

There is substantial evidence supporting an association between psychiatric disorders and abnormalities in stress-related biological systems, such as the HPA axis and inflammatory responses.[19, 20] These abnormalities could provide a basis for investigating a relationship between telomere shortening and accelerated ageing.[21, 22]

Chronological ageing impairs an organism's ability to sustain efficient allostasis when responding to different stressors. This is well demonstrated by examining physiological regulation of HPA axis responses. The cortisol response to stressors can be exaggerated in the elderly, with a slow negative feedback, so that cortisol stays elevated for longer.[23] The actual significance of hypercortisolaemia remains unknown, and it is still debatable whether ‘hypercortisolaemia’ results in net hypercortisolism at the cellular level or rather in net hypocortisolism due to a downregulation of the GC receptor. Furthermore, in some situations, hypercortisolaemia could represent a homeostatic attempt to overcome GC-receptor resistance.[22] Thus, cortisol levels in blood do not necessarily reflect cortisol signalling at the cellular and genomic levels.[24] In fact, the research linking chronic stress, telomere system and HPA function is sometimes contradictory, and some studies reporting increased activation of telomerase activity, while others describe the opposite.[25]

Psychological and oxidative stress-related with increased HPA activity and the telomere system

Recently, a meta-analysis of GC as modulators of oxidative stress showed that they increased oxidative stress with duration of treatment. In addition, GCs cause different levels of oxidative stress among different tissues, with the brain being the most susceptible to damage.[26] It seems that chronic psychological stress is perceived by the cortex of the brain, inducing secretion of hypothalamic corticotrophin-releasing hormone (CRH), leading to increases in ACTH and cortisol levels, which could be used as an index of stress reactivity. Chronic stress is believed to favour disease by activating the HPA axis.[21, 27] This stress-related dysregulation of the HPA axis leads to cortisol-induced changes such as reduced availability of intracellular glucose energy stores, neurotoxic effects in certain brain areas (prefrontal cortex and hippocampus), excitotoxicity (increasing glutamate secretion), neuroinflammation (immune alterations) and accelerated cell ageing, via effects on the telomere/telomerase maintenance system. In fact, in patients with major depression, hippocampal atrophy is often reported.[28, 29] These lesions are similar to those observed in patients with Cushing's syndrome, suggesting a possible ‘pro-ageing’ effect of GCs in certain cells of the body.[18, 30-32]

Furthermore, altered HPA axis activity together with stress can increase oxidative damage and decrease antioxidant mechanisms. Oxidative stress damage occurs when the production of oxygen free radicals exceeds the capacity of the body's antioxidants to neutralize them. Elevated plasma and/or urine oxidative stress markers have been reported in patients with depression or individuals with chronic psychological stress.[33] As mentioned earlier, the guanine-rich strand of telomeres is more sensitive to oxidative damage compared with other genome sequences.[8] In fact, oxidative stress is inversely correlated with telomerase activity as well as TL.[34-36] Therefore, accelerated telomere shortening may reflect stress-related oxidative damage to cells and accelerated ageing.

Some studies have linked accelerated leucocyte telomere shortening to several psychosocial stress situations, such as mood disorders and in caregivers, like mothers of chronically ill children or partners of patients with Alzheimer's disease. Mothers who look after a chronically ill child have shorter telomeres in peripheral blood mononuclear cells (PBMCs), relating more years of caregiving to lower telomerase activity, and higher levels of perceived stress and oxidative stress index (isoprostanes per milligram of creatinine/vitamin E) compared with controls (noncaregiving mothers).[37] These findings provide a potential mechanism for stress-associated TL attrition. Studies examining the relationship between TL and the HPA axis are summarized in Table 1.

Table 1. Studies examining the relationship between telomere system and the HPA axis
Diagnosis or type of stressReferencesTotal nFindings
  1. DST, dexamethasone; PBMCs, peripheral blood mononuclear cells.

Perceived stress (Breast cancer sisters)36647Accelerated telomere shortening with higher levels of urinary catecholamines and urinary free cortisol
Laboratory stressors3778Shorter buccal cell TL in children with higher levels of salivary cortisol and higher autonomic reactivity
High caregiver stress (dementia caregiver)3814Shorter telomeres in PBMCs were associated with greater cortisol responses and dysregulated patterns of daily cortisol secretion
3922Telomerase activity increased during acute stress associated with greater salivary cortisol increases in response to stressor
Acute mental stress4862Lower leucocyte telomerase activity was associated with exaggerated autonomic reactivity and with increased excretion of stress hormones (catecholamines and cortisol) in response to acute mental stress
Dietary restraint4056Premature telomere shortening was observed in women with dietary restraints linked to greater perceived stress and elevated salivary and urinary cortisol
High hydrocortisone levels in vitro45 50% reduction of telomerase activity of T lymphocytes was observed with exposure to high hydrocortisone levels in vitro
Embryonic exposure to corticosterone4760 (eggs)Shorter telomeres were observed with exposure to exogenous corticosterone during embryonic development (domestic chickens)
Mindfulness-based intervention for stress eating4947Changes in telomerase activity were negatively associated with changes in serum morning cortisol levels (after intervention)
Dexamethasone administration in mice thymocytes49 Rapid and dynamic loss of telomeric sequences in dexamethasone-treated thymocytes
Major Depressive Disorder and hypocortisolism5291Shorter TL was associated with depression and hypocortisolaemic state (low post-DST cortisol and high percentage of cortisol reduction after the DST)

Supporting the chronic stress model of accelerated ageing, preliminary evidence shows that certain mood disorders are associated with accelerated ageing and could be a novel mechanism for mood disorder-associated morbidity and mortality.[38] Shorter leucocyte telomeres in 44 patients with depressive mood or bipolar disorders were observed when compared to 44 gender and sex-matched control subjects, corresponding to 10 years of accelerated cell ageing.[38]

This telomere shortening, at least in part, could be related to increases in stress-related cortisol and catecholamine output. Average leucocyte telomere length was evaluated in 647 women who had a sister with breast cancer, in relation to perceived stress and urinary catecholamines and cortisol. They observed accelerated telomere shortening in the groups with higher perceived stress and with higher levels of urinary catecholamines. A trend towards telomere shortening in those with higher levels of urinary free cortisol was also observed without reaching statistical significance.[39] These results suggest that the effect of stress on TL may vary depending on neuroendocrine responsiveness and external stressors as well as on age.

Similarly, shorter buccal cell TL in children was observed in 6-year-old children exposed to laboratory stressors, with higher levels of salivary cortisol and higher autonomic reactivity. These authors suggest that buccal cell TL may be a useful marker of early biological ageing.[40]

Some preliminary data suggest that telomere shortening depends on the duration of exposure to depression or a stressor.[33] In 18 patients with major depressive disorders and 17 sex- and age-matched controls, average leucocyte telomere length was significantly inversely correlated with lifetime depression exposure, even after controlling for age.[33] This suggests that telomere shortening may progress in proportion to lifetime depression exposure and that a longer exposure to hypercortisolaemia could lead to a greater decrease in telomere length.

Greater cortisol responses and dysregulated patterns of daily cortisol secretion were associated with shorter telomeres in PBMCs in 14 postmenopausal women caring for a partner with dementia, compared with age- and BMI-matched noncaregivers.[41] Specifically, higher overnight urinary free cortisol levels, higher salivary cortisol response to acute stress and flatter daytime cortisol slopes were associated with shorter TL. However, when they evaluated TL in whole blood (mostly of short-life granulocytes), they found no relationship between TL and HPA axis dysregulation. This may be explained by the fact that these cells are not exposed to blood cortisol as much as the more long-lived circulating PBMCs, which play an active role in the early acute stress response. Future studies examining different leucocyte cell types and their relationship to TL in specific subpopulations of leucocytes may contribute to clarify these phenomena further.

Another group observed similar findings when 22 high stress dementia caregivers were exposed to a brief laboratory psychological stressor compared with 22 matched low stress controls. At baseline, caregivers had lower telomerase activity, but during acute stress telomerase activity increased similarly in both groups independently of leucocyte cell type and associated with greater salivary cortisol increases. These findings suggest novel relationships of dynamic telomerase activity with exposure to an acute stressor.[42]

Similarly, leucocyte telomere length was evaluated in a group of pre- and postmenopausal women with self-reported dietary restraints (defined as chronic worry about weight and attempts at restricting food intake), which are often linked to greater perceived stress as well as to physiological factors known to be related to long-term stress, such as elevated salivary and urinary cortisol.[43] Dietary restraint, independently of body mass index, was a risk factor for premature telomere shortening, in which HPA dysfunction could be implied.[44]

Moreover, chronic stress is related with a low health index, with an increase of cardiovascular risks factors and alterations in immunological systems, similar to what is observed in patients with Cushing's syndrome. However, the exact mechanisms involved are still unknown. Chronic stress can lead to a state of metabolic stress (overeating, co-elevations of cortisol and insulin levels and suppression of certain anabolic hormones such as androgens or GH), which in turn promotes abdominal adiposity. Both metabolic stress and abdominal adiposity can facilitate systemic inflammation and oxidative stress, which appear to mediate several cell ageing mechanisms such as leucocyte telomere length shortening and cell senescence.[45] Hence, HPA dysregulation could provide a common biological link, inducing changes in the telomere system, impairing health status and increasing cellular damage both in Cushing's syndrome and chronic psychosocial stress. Hypercortisolaemia probably contributes to premature ageing by inducing accelerated telomere shortening, which could be implied in the persistent morbidity and clinical consequences associated with Cushing's disease, even years after being biochemically cured of hypercortisolism.[18, 46]

Consistent with these observations, one study in vitro observed that exposure to high hydrocortisone levels comparable with those that might be reached in vivo during stress, is related to a significant reduction of telomerase activity in T lymphocytes, by as much as 50% 3 days later.[47] This effect is observed in both CD4 and CD8 T lymphocytes and is associated with reduced transcription of hTERT, the telomerase catalytic component. This could be one of the mechanisms in which hyperstimulation of the HPA could alter the immunological system, inducing immunosenescence and conferring higher infection susceptibility, as observed in patients with higher levels of stress or with Cushing's syndrome. These data suggest that immunosenescence may be closely related to both psychological distress and stress hormones (cortisol) and partially to telomere dysfunction.[48] Based on the hypothesis that glucocorticoids are a well-known immunosenescense inducers, Ichiyoshi et al. investigated the changes in thymocytes after dexamethasone administration in mice. They observed that dexamethasone-treated thymocytes exhibited rapid and dynamic loss of telomeric sequences and upregulation of telomerase RNA as an early event in the apoptotic process. The loss of thymocytes coincided with the appearance of small dense cells with characteristic features of apoptosis (condensed chromatin, internucleosomal DNA cleavage and hypodiploid peak on flow cytometry).[49] Some mechanisms, such as the regulation of shelterins and dyskerin expression or the regulation of genes implicated in the lengthening of telomeres (such as ATRX or DAXX) could be affected by glucocorticoids. Moreover, the methylation pattern of the subtelomeric regions either directly or indirectly by some miRNA families could also be regulated by cortisol levels. However, to our knowledge, the effect of cortisol in these possible mechanisms, which could modify telomere length, has not been evaluated and is unclear.

Recent research has observed that embryonic exposure to corticosteroids in domestic chickens resulted in higher levels of reactive oxygen metabolites and shorter telomeres compared with control birds.[50] Similarly, in 62 healthy women, it was found that lower levels of leucocyte telomerase activity were associated with exaggerated autonomic reactivity to acute mental stress and with increased excretion of stress hormones (catecholamines and cortisol). It was also observed that low telomerase activity was associated with major risk factors for cardiovascular disease (smoking, poor lipid profile, high systolic blood pressure, high fasting glucose, greater abdominal adiposity). However, PBMCs TL was not correlated with cardiovascular disease risk factors, suggesting that telomerase activity may be an earlier marker of cell ageing than TL.[51]

Recently, the first study to show a longitudinal association between coexisting changes in cortisol and telomerase activity in unstimulated PBMCs has been published.[52] The authors examined whether participation in a mindfulness-based intervention and improvements in psychological distress, eating behaviour and metabolic factors (weight, serum cortisol, fasting glucose and insulin, and insulin resistance) were associated with increases in telomerase activity in PBMCs. They observed that changes in chronic stress, anxiety, dietary restraint, cortisol and glucose were negatively correlated with changes in telomerase activity. These results support the model that changes in stress-related cortisol might be one of the signals regulating telomerase levels in humans.[52]

Psychological and oxidative-stress related with decreased HPA activity and the telomere system

Although stress has traditionally been associated with increased cortisol secretion and HPA axis overactivity, some recent literature describes low cortisol levels in certain stress-related disorders, suggesting that chronic stress could lead to an exhaustion of the HPA axis.[25] Hypocortisolaemia, or low CRH, has been related with atypical depression, states of chronic fatigue and post-traumatic stress syndrome, contributing functionally to symptoms of inflammation and fatigue.[53, 54] A recent paper reports that shorter leucocyte telomeres were associated with depression and hypocortisolism.[55] To our knowledge, telomere dysfunction has not been described in Addison's disease, the ideal model of primary endogenous hypocortisolism, or in hypopituitarism, where secondary adrenal insufficiency is often present.

Dexamethasone cortisol suppression (the percentage change of cortisol between pre- and postdexamethasone cortisol) was higher in a group of depressive patients compared with a control group. Furthermore, subjects exhibiting a high level of suppression (lower postdexamethasone cortisol levels) had significantly shorter leucocyte TL.[55] Decreased activity of the HPA axis has been shown to develop from long-term chronic stress exposure, where an initial stage of a hyperactive HPA axis eventually evolves into a hypo-active HPA axis. Highly sensitive negative feedback in the HPA axis (low postdexamethasone cortisol, high degree of cortisol suppression) is probably the most common finding in subjects exhibiting hypocortisolism. The observation of shorter TL and hypocortisolism could be the result of independent pathways of chronic stress exposure or due to higher degrees of inflammatory processes, which would lead to increased proliferation of leucocytes and higher levels of oxidative stress, both contributing to accelerated TL shortening.[3] It is difficult to know which is responsible for accelerated telomere shortening when a hypocortisolaemic state is often preceded by a hypercortisolaemic phase. The observation of shorter leucocyte TL in these situations suggests that leucocyte TL could be a good measure of cumulative stress.

To summarize, it should be noted that the effects of cortisol on the telomere system are complex and may depend on the intensity and duration of exposure. Shorter exposure and shorter duration appear stimulatory, rather than suppressive, to the telomerase system. Although acute spikes in cortisol could be associated with a short-term increase in telomerase, they are also associated with a longer term shortening of leucocyte telomere length, suggesting that, over time, stress and cortisol reactivity could promote telomere shortening.

We should consider some important limitations of the available studies that could provide explanations for the differences observed. Different methods to measure cortisol exposure have been used (questionnaires, circadian rhythm disruption, urinary free cortisol, salivary cortisol, response to dexamethasone, hydrocortisone exposure in vitro). Moreover, different methods to measure telomere length have been reported, mostly conventional techniques (Southern blot, PCR), while none of the presented studies use novel technologies such us STELA, which seems to show a better relationship with ageing and disease.

Future research will ideally enable further investigations into longitudinal changes in telomeres.

Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system

  1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References

It is well known that leucocyte TL reduces with increasing age. The shortening of telomeres may act as a mitotic clock regulating the number of divisions a cell can undergo, being a biomarker of ageing.[4, 56] However, in elderly men, TL may not decrease further, reaching a plateau, possibly due to selection by mortality, meaning that mortality may increase in men with shorter telomeres and the disappearance of men with shorter telomeres would result in an increase in the mean value in the remaining men. Alternatively, telomerase may be more active in increasing leucocyte TL in men with critically short leucocyte TL.[57]

IGF-1 is an important regulator of cell growth and proliferation. Its serum concentration reduces with increasing age. Also, serum IGF-1 concentration, with increasing age, is positively associated with parameters reflecting general health such as lean mass, physical activity and nutritional intake. Relatively low circulating levels of IGF-1 in humans are associated with age-related diseases and decrease in longevity. Diminished longevity has been observed in pathological situations, which display low levels of IGF-1 such us hypopituitarism due to multifactorial reasons compared with age- and sex-matched controls.[58] In GH resistance syndromes or untreated patients with isolated childhood-onset GH deficiency reduced longevity has also been observed.[59]

Despite these links between GH/IGF-1 and good metabolic health in humans, IGF-1 has been linked to shorter lifespan in lower species and some mammalian models.[60] Therefore, the link between IGF-1 and longevity, in humans, does not fit neatly into a simple paradigm; for these reasons, some groups have examined the association of leucocyte TL with circulating levels of IGF-1. Low levels of IGF-1, and also short leucocyte TL, are associated with age-related diseases, mainly atherosclerosis and diminished longevity. Barbieri et al. examined this possible association in healthy individuals free of any major ageing-related diseases. Both variables, leucocyte TL and IGF-1, diminished with age and showed positive and strong correlations between each other.[61] Therefore, short leucocyte TL may be a reflection of the poor general health in these men.

On the other hand, IGF-1 may reduce inflammation, which could have a protective role against telomere attrition. IGF-1 acts as an anti-inflammatory molecule inhibiting IL-6 expression and increasing its clearance. Both higher IL-6 and lower IGF-1 levels confer increased risk of having metabolic syndrome.[62] IGF-1 seems to upregulate nitric oxide synthase in the vascular endothelium, which would cause vasorelaxation, a beneficial phenomenon to the ageing vasculature, which also would decrease oxidative stress/inflammation.[63] This systemic effect of IGF-1 might ultimately explain the link between IGF-1 and TL in humans. Additionally, low serum IGF-1 concentration has been found to be a risk factor for ischaemic heart disease, congestive heart failure and even for increased mortality.[64] It is not clear whether the positive relation between IGF-1 concentration and TL reflects a single association or a cause and effect relationship.

The possible interaction between circulating IGF-1 and TL has been studied in a few series. Table 2 summarizes studies examining the relationship between the telomere system and the GH/IGF-1 axis.

Table 2. Studies examining the relationship between TL and the GH/IGF1 axis
Study populationReferencesTotal nFindings
  1. TL, telomere lenght; MNC, mononuclear cells; PHA, phytohaemagglutinin; IGF1, insulin growth factor 1.

Healthy subjects58476Longer leucocyte TL were associated with higher circulating levels of IGF1
In vitro: cord blood MNC stimulated by PHA62 IGF1 increased telomerase activity in PHA stimulated cells
Participants among the cardiovascular health study (adult men)63551Higher IGF1 values may be an independent predictor of longer leucocyte TL
Elderly men642744TL was positively associated with serum IGF1 and negatively associated with age

IGF-1 affects cell replication and is involved in growth, proliferation and transformation of many cell types. It plays a critical role in the G1 and S phase of the cell cycle. On its own, it cannot stimulate entry into the G1 phase, but it is thought to be necessary for maintaining G1 and entry into the S phase in many cell types, including mitogen-stimulated human leucocytes. Therefore, IGF-1 could be a tangible candidate involved in telomerase activation in cell growth and proliferation. Upregulation of telomerase activity by IGF-1 has been observed in several cancer cell lines.[65] For the first time, Tu et al. in 1999 studied in vitro the effect of IGF-1 on telomerase activity and on telomerase component's complex in human cord blood mononuclear cells. Interestingly, IGF-1 alone did not increase the telomerase activity of cord blood mononuclear cells but could enhance the phytohaemagglutinin-induced (T-cell stimulating agent) increase in telomerase activity. The results suggested that IGF-1 may modulate telomerase activity supporting its potential role in increasing replicative potential of cord blood lymphoid cells or haematopoietic stem cells. Nevertheless, little is known about whether these two systems interact in vivo[66] The mechanisms of telomerase activation in cancer cells by IGF-1 and the potential effects of IGF-1 on telomerase in normal somatic cells need to be further elucidated.

In a recent study, the relationship between leucocyte TL and IGF-1 in 551 adults older than 65 years was evaluated. No correlation between TL and plasma IGF-1 concentration was observed in univariate regression analysis. However, in multivariate regression analysis, a positive association between plasma IGF-1 and TL was observed after adjustment for multiple confounding factors, such as age, sex, race, smoking status, body mass index, hypertension, diabetes and serum lipids.[67] The results of this study suggest that higher IGF-1 values may be an independent predictor of longer leucocyte TL, consistent with prior evidence suggesting a role of IGF-1 in mechanisms related to telomere maintenance in immune cells.[67] They also observed that this association was stronger in men than in women, possibly due to gender differences in the regulation of leucocyte TL.

Another large population-based cross-sectional study with 2744 elderly men (mean age 75·5 years), observed that leucocyte telomere length was positively associated with serum IGF-1 and negatively associated with age.[68] In contrast with other studies, in this last series, leucocyte TL was independently associated with serum C-reactive protein concentrations, where IGF-1 seems to reduce inflammation.[62]

Mechanisms underlying the association between TL, IGF-1 and senescence remain to be determined. It is not fully clear whether measurements of TL in leucocytes are representative of the processes that occur in other somatic cells, as TL may differ by cell type. Nevertheless, there are correlations between TL in different tissues, which suggests that TL in leucocytes could serve as a surrogate for relative TL in other tissues. We must also take into account that telomere shortening and IGF-1 axis are not the only mechanisms that affect cell senescence; environmental stress-mediated accumulations of DNA mutations (reactive oxygen species, ultraviolet irradiation, chemical mutagens or endocrine signals such us IGF-1/insulin signalling) and the intrinsically encoded biological clock that dictates lifespan events of any particular cell type can also affect cell senescence. Some genes implied in the regulation of the mechanism of alternative lengthening of telomeres such as ATRX (ATP-dependent helicase) or DAXX (death domain-associated protein) participate in chromatin remodelling of telomeres and other genomic sites. In ATRX-null embryonic mice, which exhibit telomere dysfunction, reduced growth and shortened lifespan, DNA damage and tissue attrition are found in the anterior pituitary cells, resulting in low circulating levels of IGF-1.[69] On the other hand, a type III protein deacetylase (SIRT1) is considered a novel anti-ageing protein involved in regulation of cellular senescence/ageing and inflammation, being a positive regulator of telomere length in vivo. SIRT1 has been shown to modulate the activity of FoxO, a transcriptor factor that is downstream of the IGF signalling system. The loss of SIRT1 in mice results in increased expression of the IGF-binding protein type 1 (IGFBP1), a modulator of IGF-1 function. Whether these alterations are also present in humans, and any potential effects on telomere system, are unclear.[70]

These mechanisms are directly tied to changes in nuclear function and structure and affect both somatic and stem cells, which are responsible for proper tissue rejuvenation.[71]

To our knowledge, the telomere system has not been evaluated in patients with acromegaly, where excessive amounts of GH and consequently IGF1 are produced.

Further investigations are necessary to examine how the interplay between the GH/IGF1 system and telomere regulation affects immune ageing and the risk of age-associated diseases.

To summarize, telomeres are essential to maintain genomic stability. When telomeres are critically short, cell division stops, and senescence and apoptosis are induced. Telomere length can be influenced and modified by genetic, epigenetic, environmental and hormonal factors. The review focuses on the possible relationships between telomere dysfunction and the HPA axis on the one hand and the GH-IGF-1 system on the other.

Most of the evidence linking the telomere system and HPA function has been evaluated in psychiatric diseases (chronic stress, post-traumatic stress disorders and major depression), where hypercortisolism is often present. Some of the findings have been contradictory, with some studies reporting increased activation of telomerase activity, while a few others conclude the opposite. The possible mechanisms by which cortisol could modify telomere length have not been systematically evaluated and are presently unclear.

Both IGF-1 and TL diminish with age and are positively and strongly correlated. Low levels of IGF-1 are associated with inflammation and ageing-related diseases, processes in which TL has been found to be reduced. However, mechanisms underlying the association between TL, IGF-1 and senescence remain to be determined.

TL dysfunctions have not yet been evaluated in either endogenous hypercortisolism due to Cushing's syndrome or in acromegaly where excessive amounts of cortisol or IGF-1, respectively, are present.


  1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References

AA is supported by a grant from Spanish Ministry of Health, ISCIII, PI 11/00001 and by a Young Investigator Award of Spanish Endocrine Society Foundation.


  1. Top of page
  2. Summary
  3. Introduction
  4. Hypothalamic–pituitary–adrenal axis and the telomere system
  5. Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) axis and the telomere system
  6. Acknowledgements
  7. Conflict of interest
  8. References
  • 1
    Calado, R.T. & Young, N.S. (2009) Telomere Disease. New England Journal of Medicine, 361, 23532365.
  • 2
    Lin, K.W. & Yan, J. (2005) The telomeres length dynamic and methods of its assessment. Journal of Cell and Molecular Medicine, 9, 977989.
  • 3
    Oeseburg, H., de Boer, R.A., van Gilst, W.H. et al. (2010) Telomere biology in healthy aging and disease. European Journal of Physiology, 459, 259268.
  • 4
    Takubo, K., Aida, J., Izumiyama-Shimomura, N. et al. (2010) Changes of telomere length with aging. Geriatrics Gerontology International, 10, S197S206.
  • 5
    Aubert, G. & Landsdorp, P.M. (2008) Telomeres and aging. Physiological Reviews, 88, 557579.
  • 6
    Zhu, H., Belcher, M. & van der Harst, P. (2011) Healthy aging and disease: role for telomere biology? Clinical Science, 120, 427440.
  • 7
    Houben, J.M.J., Moonen, H.J.J., van Schooten, F.J. et al. (2008) Telomere length assessment: biomarker of chronic oxidative stress? Free Radical Biology & Medicine, 44, 235246.
  • 8
    Petersen, S., Saretzki, G. & von Zglinicki, T. (1998) Preferential accumulation of single-stranded regions in telomeres of humans fibroblasts. Experimental Cell Research, 239, 152160.
  • 9
    Blasco, M.A. (2007) Telomere length, stem cells and aging. Nature Chemical Biology, 3, 640649.
  • 10
    Svenson, U., Nordfjäll, K., Baird, D. et al. (2011) Blood cell telomere length is a dynamic feature. PLoS ONE, 6, e21485.
  • 11
    Price, L.H., Kao, H.T., Burgers, D.E. et al. (2013) Telomeres and early-life stress: an overview. Biological Psychiatry, 73, 1523.
  • 12
    Traustadottir, T., Bosch, P.R. & Matt, K.S. (2005) The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology, 30, 392402.
  • 13
    Ornish, D., Lin, J., Daubenmier, J. et al. (2008) Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncology, 9, 10481057.
  • 14
    Balasubramanyam, M., Adaikalakoteswari, A., Sameermahmood, Z. et al. (2010) Biomarkers of oxidative stress: methods and measures of oxidative DNA damage (COMET Assay) and telomere shortening, Methods in Molecular Biology, 610, 245261.
  • 15
    Ma, H., Zhou, Z., Wei, S. et al. (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE, 6, e20466.
  • 16
    Young, N.S. (2012) Bone marroy failure and the new telomere diseases: practice and research. Hematology, 17(Suppl 1), S18S21.
  • 17
    Willeit, P., Willeit, J., Brandstätter, A. et al. (2010) Cellular aging reflected by leukocyte telomere length predicts advanced atherosclesoris and cardiovascular disease risk. Arteriosclerosis Thrombosis, and Vascular Biology, 30, 16491656.
  • 18
    Aulinas, A., Santos, A., Valassi, E. et al. (2013) Telómeros, envejecimiento y síndrome de Cushing: ¿están relacionados? Endocrinología y Nutrición, 60, 329335.
  • 19
    Pariante, C.M. & Miller, A.H. (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391404.
  • 20
    Wolkowitz, O.M., Epel, E.S., Reus, V.I. et al. (2010) Depression gets old fast: do stress and depression accelerate cell aging? Depression and Anxiety, 27, 327338.
  • 21
    Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C. et al. (1994) Increased numbers of corticotrophin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology, 60, 436444.
  • 22
    Price, L.H., Kao, H.T., Burgers, D.E. et al. (2013) Telomeres and early-life stress: an overview. Biological Psychiatry, 73, 1523.
  • 23
    Otte, C., Hart, S., Neylan, T.C. et al. (2005) A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology, 30, 8091.
  • 24
    Miller, G.E., Chen, E., Sze, J. et al. (2008) A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biological Psychiatry, 64, 266272.
  • 25
    Miller, G.E., Chen, E. & Zhou, E.S. (2007) If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychological Bulletin, 133, 2545.
  • 26
    Costantini, D., Marasco, V. & Moller, A.P. (2011) A meta-analysis of glucocorticoids as modulators of oxidative stress in vertebrates. Journal of Comparative Physiology. B, Biochemical, Systemic and Environmental Physiology, 181, 447456.
  • 27
    Swaab, D.F., Bao, A.M. & Lucassen, P.J. (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Research Reviews, 4, 141194.
  • 28
    Belmaker, R.H. & Agam, G. (2008) Mechanisms of disease. Major Depressive Disorder. New England Journal of Medicine, 358, 6668.
  • 29
    Lupien, S.J., de Leon, M., de Santi, S. et al. (1998) Cortisol levels during human ageing predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1, 6973.
  • 30
    Wolkowitz, O.M., Burke, H., Epel, E. et al. (2009) Glucocorticoids: mood, memory and mechanisms, Glucocorticoids and Mood. Annals of the New York Academy of Sciences, 1179, 1940.
  • 31
    Resmini, E., Santos, A., Gómez-Anson, B. et al. (2012) Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 97, 663671.
  • 32
    Michaud, K., Forget, H. & Cohen, H. (2009) Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain and Cognition, 71, 18.
  • 33
    Wolkowitz, O.M., Mellon, S.H., Epel, E.S. et al. (2011) Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress – preliminary findings. PLoS ONE, 6, e17837.
  • 34
    Harbo, M., Koelvraa, S., Serakinci, N. et al. (2012) Telomere dynamics in human mesenchymal stem cells after exposure to acute oxidative stress. DNA Repair, 11, 774779.
  • 35
    von Zglinicki, T., Saretzki, G. & Döcke, W. (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Experimental Cell Research, 220, 186193.
  • 36
    Von Zglinicki, T. (2000) Role of oxidative stress in telomere length regulation and replicative senescence. Annals of the New York Academy of Sciences, 908, 327330.
  • 37
    Epel, E.S., Blackburn, E.H., Lin, J. et al. (2004) Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 1731217315.
  • 38
    Simon, N.M., Smoller, J.W., McNamara, K.L. et al. (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological Psychiatry, 60, 432435.
  • 39
    Parks, G.C., Miller, D.B., McCanlies, E.C. et al. (2009) Telomere length, current perceived stress, and urinary stress hormones in women. Cancer Epidemiology, Biomarkers & Prevention, 18, 551560.
  • 40
    Kroenke, C.H., Epel, E., Adler, N. et al. (2011) Autonomic and adrenocortical reactivity and buccal cell telomere length in kindergarten children. Psychosomatic Medicine, 73, 533540.
  • 41
    Tomiyama, A.F., O'Donovan, A., Lin, J. et al. (2012) Does cellular aging relate to patterns of allostasis? An examination of basal and stress reactive HPA axis activity and telomere length. Physiology & Behavior, 106, 4045.
  • 42
    Epel, E., Lin, J., Dhabhar, F.S. et al. (2010) Dynamics of telomerase activity in response to acute psychological stress. Brain, Behavior, and Immunity, 24, 531539.
  • 43
    Kiefer, A., Lin, J., Blackburn, E. et al. (2008) Dietary restraint and telomere length in pre- and postmenopausal women. Psychosomatic Medicine, 70, 845849.
  • 44
    Anderson, D.A., Shapiro, J.R., Lundgren, J.D. et al. (2002) Self-reported dietary restraint is associated with elevated levels of salivary cortisol. Appetite, 38, 1317.
  • 45
    Epel, E. (2009) Psychological and metabolic stress: a recipe for accelerated cellular aging? Hormones, 8, 722.
  • 46
    Valassi, E., Crespo, I. & Santos, A. (2012) Clinical consequences of Cushing's syndrome. Pituitary, 15, 319329.
  • 47
    Choi, J., Fauce, S.R. & Effros, R.B. (2008) Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain, Behavior, and Immunity, 22, 600605.
  • 48
    Bauer, M.E. (2005) Stress, glucocorticoids and ageing of the immune system. Stress, 8, 6983.
  • 49
    Ichiyoshi, H., Kiyozuka, Y., Kishimoto, Y. et al. (2003) Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Experimental and Molecular Pathology, 75, 178186.
  • 50
    Haussmann, M.F., Longenecker, A.S., Marchetto, N.M. et al. (2012) Embryonic exposure to corticosterone modifies the juvenil stress response, oxidative stress and telomere length. Proceedings. Biological Sciences/The Royal Society, 279, 14471456.
  • 51
    Epel, E., Lin, J., Wilhelm, F.H. et al. (2006) Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology, 31, 277287.
  • 52
    Daubenmier, J., Lin, J., Blackburn, E. et al. (2012) Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in randomized mindfulness intervention pilot study. Psychoneuroendocrinology, 37, 917928.
  • 53
    Gold, P.W. & Chrousos, G.P. (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry, 7, 254275.
  • 54
    Fries, E., Hesse, J., Hellhammer, J. et al. (2005) A new view on hypocortisolism.Psychoneuroendocrinology, 30, 10101016.
  • 55
    Wikgren, M., Maripuu, M., Karlsson, T. et al. (2012) Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biological Psychiatry, 71, 294300.
  • 56
    Bekaert, S., de Meyer, T. & Van Oostveldt, P. (2005) Telomere attrition as ageing biomarker. Anticancer Research, 25, 30113022.
  • 57
    Bischoff, C., Graakjaer, J., Petersen, H.C. et al. (2005) Telomere length among the elderly and oldest-old. Twin Research and Human Genetics: The Official Journal of the International Society for Twin Studies, 8, 425432.
  • 58
    Bates, A.S., Van't Hoff, W., Jones, P.J. et al. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 11691172.
  • 59
    Besson, A., Salemi, S., Gallati, S. et al. (2003) Reduced longevity in untreated patients with isolated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 88, 36643667.
  • 60
    Berryman, D.E., Christiansen, J.S., Johannsson, G. et al. (2008) Role of the GH/IGF1 axis in lifespan and healthspan: lessons from animal models. Growth Hormone and IGF Research, 18, 455471.
  • 61
    Barbieri, M., Paolisso, G., Kimura, M. et al. (2009) Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjects. Mechanisms of Ageing and Development, 130, 771776.
  • 62
    Succurro, E., Andreozzi, F., Sciagua, A. et al. (2008) Reciprocal association of plasma IGF1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care, 31, 18861888.
  • 63
    Sukhanov, S., Higashi, Y., Shai, S.Y. et al. (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arteriosclerosis Thrombosis, and Vascular Biology, 27, 26842690.
  • 64
    Laughlin, G.A., Barrett-Connor, E., Criqui, M.H. et al. (2004) The prospective association of serum insulin-like growth factor I (IGFI) and IGF-binding protein-1 with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism, 89, 114120.
  • 65
    Wetterau, L.A., Francis, M.J.Ma, L. et al. (2003) Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells. Journal of Clinical Endocrinology and Metabolism, 88, 33543359.
  • 66
    Tu, W., Zhang, D.K., Cheung, P.T. et al. (1999) Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. British Journal of Haematology, 104, 785794.
  • 67
    Kaplan, R.C., Fitzpatrick, A.L., Pollak, M.N. et al. (2009) Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study. Journal of Gerontology. Series A, Biological Sciences and Medical Sciences, 11, 11031106.
  • 68
    Movérare-Skrtic, S., Svensson, J., Karlsson, M.K. et al. (2009) Serum Insulin-Like Growth Factor-1 concentration is associated with leukocyte telomere length in a population-based cohort of elderly men. Journal of Clinical Endocrinology and Metabolism, 94, 50785084.
  • 69
    Watson, L.A., Solomon, L.A., Li, J.R. et al. (2013) ATRX deficiency induces telomere dysfunction, endocrine defects and reduced life span. The Journal of Clinical Investigation, 123, 20492063.
  • 70
    Lemieux, M.E., Yang, X., Jardine, K. et al. (2005) The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals. Mechanisms of Ageing and Development, 126, 10971105.
  • 71
    Shin, D.M., Kucia, M. & Ratajczak, M.Z. (2011) Nuclear and chromatin reorganization during cell senescence and aging – a mini review. Gerontology, 57, 7684.